| 摘要 |
<p>The present invention relates to novel compounds for inhibition of angiogenesis receptor tyrosine kinases, in particular, VEGF receptor 2 kinase ("KDR") activity, and preparations for preparation of them, and the use of them, and pharmaceutical compositions containing them at a therapeutically effective amount. The compounds according to the present invention are useful for the treatment and prevention of diseases resulting from the undesired KDR activity, for example, angiogenesis-related diseases such as cancers, psoriasis, rheumatoid arthritis, diabetic retinopathy, etc.</p> |
| 申请人 |
LG LIFE SCIENCES, LTD.;YOON, SEUNG-HYUN;JOO, HYUN WOO;SONG, JEONG UK;KIM, YOUNG KWAN;KOO, SUN-YOUNG;YANG, SO YEUN;KIM, KYOUNG-HEE;HWANG, JIN-A;CHO, HEUNG SOO;CHOI, HWAN GEUN;LIM, DONGCHUL;SONG, JI SOO;YOON, HAE-SEONG;HONG, SANG-YONG;KIM, MIN-JEONG;CHOI, SEIHYUN;JO, KIWON;KIM, MIN-HYEUNG;KIM, JIEUN;KIM, JUNG IN;PARK, TAE KYO |
发明人 |
YOON, SEUNG-HYUN;JOO, HYUN WOO;SONG, JEONG UK;KIM, YOUNG KWAN;KOO, SUN-YOUNG;YANG, SO YEUN;KIM, KYOUNG-HEE;HWANG, JIN-A;CHO, HEUNG SOO;CHOI, HWAN GEUN;LIM, DONGCHUL;SONG, JI SOO;YOON, HAE-SEONG;HONG, SANG-YONG;KIM, MIN-JEONG;CHOI, SEIHYUN;JO, KIWON;KIM, MIN-HYEUNG;KIM, JIEUN;KIM, JUNG IN;PARK, TAE KYO |
